4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-25-028896
Director sold 3,200 shares at $5.05 ($16,149)
- Director acquired 8,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Napolitano Janet Director | 2025-05-30 | Grant or award 10b5-1 | +8,000 | 19,616 | D | ||
| Napolitano Janet Director | 2025-06-02 | Sale 10b5-1 | −3,200 | $5.05 | $16,149 | 16,416 | D |
| Derivatives | |||||||
| Napolitano Janet Director | 2025-05-30 | Grant or award · Stock Option (Right to Buy) 10b5-1 | +16,000 | 16,000 | D | ||
| Open-market sales · 3,200 sh · avg $5.05 · $16,149 | |||||||
Loading xslF345X05/wk-form4_1748906763.xml…